共查询到20条相似文献，搜索用时 203 毫秒
1.
将临床收集确诊的40只细小病毒病犬分为黄芪多糖组和常规治疗组，对黄芪多糖是否具有治疗犬细小病毒病的作用进行试验研究。并以犬血常规变化来检验其疗效。结果表明：细小病毒病以2～5月龄犬发病较多，并以肠炎型为主。犬感染细小病毒后白细胞数、红细胞数、血红蛋白含量、红细胞压积均低于正常值范围。黄芪多糖能够升高病犬白细胞数、红细胞数、血红蛋白含量，除红细胞数外，在治疗第6天均恢复到正常水平。黄芪多糖能够升高病犬血清中SOD的活性，治疗第6天与基础值比较差异极显著（P〈0．01）；同时能够降低病犬血清中MDA的含量，在治疗第6天与基础值比较差异极显著（〈O．01），与健康对照组相近。黄芪多糖组治愈率为90％．常规治疗组治愈率为70％。 相似文献
2.
将临床收集确诊的40只细小病毒病犬分为黄芪多糖组和常规治疗组,对黄芪多糖是否具有治疗犬细小病毒病的作用进行试验研究,并以犬血常规变化来检验其疗效.结果表明:细小病毒病以2～5月龄犬发病较多,并以肠炎型为主.犬感染细小病毒后白细胞数、红细胞数、血红蛋白含量、红细胞压积均低于正常值范围.黄芪多糖能够升高病犬白细胞数、红细胞数、血红蛋白含量,除红细胞数外,在治疗第6天均恢复到正常水平.黄芪多糖能够升高病犬血清中SOD的活性,治疗第6天与基础值比较差异极显著(P＜0.01);同时能够降低病犬血清中MDA的含量,在治疗第6天与基础值比较差异极显著(P＜0.01),与健康对照组相近.黄芪多糖组治愈率为90%,常规治疗组治愈率为70%. 相似文献
3.
4.
《黑龙江畜牧兽医》2010,(5)
为了研究激素冲击疗法对肺炎型犬瘟热病犬的血常规的影响,试验采用常规疗法的同时给患犬静脉注射地塞米松2mg/kg行激素冲击疗法,并于试验前和每天用药后4小时采血,用CA-500血液分析仪测定白细胞(WBC)数、淋巴细胞(LYM)数、中间细胞(MON)比率、红细胞(RBC)数、血红蛋白(HGB)含量、血小板(PLT)数等指标,以治疗前测定值为基础值,观察激素冲击疗法后病犬血常规的变化。结果表明:对照组病犬WBC数、MON比率无显著变化,LYM数在治疗结束时极显著降低(P0.01)。试验组WBC在用药后2天就显著升高(P0.05),第3天极显著升高(P0.01);LYM在用药后1天就显著升高(P0.05);其他参数如红细胞、血小板无显著变化。 相似文献
5.
为评价黄芪多糖铁对缺铁性贫血小白鼠的补铁作用,采用苯肼诱导法制成小白鼠贫血模型。以硫酸亚铁和右旋糖酐铁为对照药物,在给药后第2天、第5天、第10天进行尾部采血,测定各组小白鼠不同时期血液中的红细胞数、血红蛋白、血清铁及血清铁蛋白含量。结果表明,黄芪多糖铁可以显著提高贫血小鼠的红细胞数、血红蛋白、血清铁及血清铁蛋白含量。 相似文献
6.
以犬为研究对象,探讨黄芪多糖注射液肌肉注射对犬脾虚泄泻证的临床治疗效果。24只健康本地犬饲养1周后灌胃番泻叶水煎剂人工复制脾虚泄泻证病理模型,造模成功后随机分为3组：黄芪多糖注射液治疗组肌肉注射黄芪多糖注射液0．25mL／kg,2次／d;庆大霉素组肌肉注射庆大霉素注射液0．2mL／kg,2次／d;病理对照组不作任何处理;同时设立4头健康犬作为空白对照,造模期间灌胃生理盐水。治愈后检测试验犬体质量、三大临床指标、白细胞、红细胞、血红蛋白及脾脏指数,并进行统计分析。结果表明,黄芪多糖注射液治疗组治愈后白细胞、血红蛋白、红细胞恢复较快,平均日增重及脾脏指数显著高于庆大霉素治疗组（p〈0．05）;三大临床指标各治疗组差异不显著（P〉0．05）。说明黄芪多糖注射液可用于临床治疗动物脾虚泄泻证。 相似文献
7.
犬细小病毒病是由犬细小病毒（cpv）引起的一种急性传染病，发病率和死亡率比较高，达10％～50％，自愈率〈5％．笔者在近一年中的犬病治疗过程中用犬细小病毒快速诊断试纸条确诊为犬细小病毒病的有16例。经过临床治疗得出，除了采用高免血清和对症治疗外，治愈率的高低在很大程度上取决于输液，此外对病犬的护理正确精细与否也有一定的关系。本文重点介绍了犬细小病毒病的临床症状、剖检变化、鉴别诊断、治疗情况及治疗体会。 相似文献
8.
范豪杰 《江西畜牧兽医杂志》2014,(2):31-31
<正>犬细小病毒病是由犬细小病毒感染幼犬后引起的一种急性、接触性传染病,常发生于2~6月龄幼犬,未免疫幼犬普遍易感,且致死率极高,对养犬业造成严重危害。临床症状表现为急性出血性肠炎及心肌炎特征,临床主要采取抗犬细小病毒血清抗病毒治疗以及对症治疗,但伴有心肌炎的幼犬常预后不良。我们通过联合应用黄芪多糖及丹参注射液治疗,获得了较好效果。1材料与方法1.1诊断依据1.1.1临床症状。病犬体温升高,精神沉郁,目光呆滞,不爱走动,喜欢趴在阴暗处,食欲下降或废食, 相似文献
9.
以犬为研究对象,探讨黄芪多糖注射液肌肉注射对犬脾虚泄泻证的临床治疗效果。24只健康本地犬饲养1周后灌胃番泻叶水煎剂人工复制脾虚泄泻证病理模型,造模成功后随机分为3组:黄芪多糖注射液治疗组肌肉注射黄芪多糖注射液0.25mL/kg,2次/d;庆大霉素组肌肉注射庆大霉素注射液0.2mL/kg,2次/d;病理对照组不作任何处理;同时设立4头健康犬作为空白对照,造模期间灌胃生理盐水。治愈后检测试验犬体质量、三大临床指标、白细胞、红细胞、血红蛋白及脾脏指数,并进行统计分析。结果表明,黄芪多糖注射液治疗组治愈后白细胞、血红蛋白、红细胞恢复较快,平均日增重及脾脏指数显著高于庆大霉素治疗组(P<0.05);三大临床指标各治疗组差异不显著(P>0.05)。说明黄芪多糖注射液可用于临床治疗动物脾虚泄泻证。 相似文献
10.
《中国动物保健》2017,(12)
本试验旨在探讨大黄注射液治疗犬瘟热的应用效果。试验现随机选取2015年8月—2016年8月我诊所收治的犬瘟热病犬50例作为研究对象,分为试验组25例和对照组25例,对照组给予五连血清进行治疗,试验组在对照组的基础上给予大黄注射液治疗,对两组病犬的治疗效果进行对比和分析。结果:两组病犬治疗前的淋巴细胞数、红细胞数和白细胞数差异不明显,不具有统计学意义(P0.05),治疗后试验组病犬的淋巴细胞数、红细胞数和白细胞数明显优于对照组,组间差异明显具有统计学意义(P0.05)。结论:在犬瘟热的治疗中,可应用大黄注射液进行治疗,能够明显改善病犬的淋巴细胞、红细胞和白细胞水平,临床应用效果良好,值得推广和应用。 相似文献
11.
为探究犬细小病毒（canine parvovirus,CPV）血清型只有一种的条件下,常用疫苗CPV-2型和CPV-2a病毒免疫血清抗体对国内流行CPV-2a病毒的中和率,试验将藏獒源CPV-2a毒株（105 TCID50/100 μL）和CPV-2（104.5 TCID50/100 μL）疫苗接于F81细胞增殖,PEG6000法浓缩制成免疫原,各免疫新西兰长白兔3只,间隔2周1次,共免疫4次。收集血清纯化制备多克隆抗体,通过血凝抑制试验（HI）和血清中和试验（SN）分别用2种抗体中和CPV-2、CPV-2a病毒,对两者保护率进行初步评价,并对本地感染CPV-2a的4只犬,每组2只进行治疗,每日跟踪白细胞消长规律。结果显示,CPV-2a多抗中和国内流行病毒CPV-2a的HI抗体、中和抗体水平都极显著高于CPV-2多抗（P<0.01）,而中和CPV-2病毒的HI抗体、中和抗体水平两者差异不显著（P>0.05）,CPV-2a多抗组治疗能较快恢复正常值,2组白细胞数有显著差异（P＜0.05）。结果表明,CPV-2a多抗与常用CPV-2型疫苗免疫抗体相比能高滴度的中和CPV-2a,更适用于中国犬细小病毒的防制,对研发新型生物制品有一定意义。 相似文献
12.
为了观察盐酸多西环素对急性期犬埃立克体病的治疗效果,对人工感染埃立克体的比格犬进行了盐酸多西环素的治疗试验。采集比格犬感染前及治疗前后的血液样本,测定血常规及各项血生化指标,并对测定结果作统计学处理。血常规检测发现与治疗前相比,治疗后RBC、WBC、HGB、PLT、MPV、NEU-TRO、LYM、MONO和RDW显著升高;HCT、MCV、MCH和MCHC无明显变化;血生化检测发现,与治疗前相比,治疗后ALT和AST显著降低,ALB显著升高;治疗后与感染前相比,血常规和血生化各项均没有显著变化。进一步证实了盐酸多西环素对犬埃立克体病急性期病例具有良好的治疗效果。 相似文献
13.
Ruotsalo K Poma R da Costa RC Bienzle D 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2008,37(2):242-248
BACKGROUND: Conventional techniques for canine cerebrospinal fluid (CSF) analysis require large sample volumes and are labor intensive and subject to operator variability. Objective: The purpose of this study was to evaluate the ADVIA120 CSF assay for analysis of canine CSF samples. METHODS: CSF samples collected from 36 healthy control dogs and 17 dogs with neurologic disease were processed in parallel using the automated assay and established manual methods using a hemocytometer and cytocentrifugation. Results for WBC (total nucleated cell) count, RBC count, and differential nucleated cell percentages were compared using Spearman rank correlation coefficients and Bland-Altman bias plots. RESULTS: Correlation coefficients for WBC and RBC counts were 0.57 and 0.83 for controls, and 0.92 and 0.94 for ill dogs, respectively. Coefficients for the percentages of neutrophils, lymphocytes, and monocytes were 0.53, 0.26, and 0.12 for controls and 0.77, 0.92, and 0.70 for dogs with neurologic disease. When data were combined (n=53), correlation coefficients were 0.86 and 0.91 for WBC and RBC counts, and 0.63, 0.43, and 0.30 for neutrophil, lymphocyte, and monocyte percentages. A 9.5% positive bias and 7.0% negative bias were obtained for the ADVIA 120 CSF assay for lymphocytes and macrophages in dogs with neurologic disease with Bland-Altman analysis. A 12.2% positive bias was found for lymphocyte percentage in dogs with neurologic disease. CONCLUSIONS: Manual and automated CSF assays had moderate to excellent correlation for WBC and RBC concentrations, but results were more variable for differential cell percentages. The ADVIA assay may be more useful for assessment of canine CSF with adjustment of cell differentiation algorithms. 相似文献
14.
A. DUFFY S. DOW G. OGILVIE S. RAO T. HACKETT 《Journal of veterinary pharmacology and therapeutics》2010,33(4):352-356
Duffy A., Dow S., Ogilvie G., Rao S., Hackett T. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte‐colony stimulating factor. J. vet. Pharmacol. Therap. doi: 10.1111/j.1365‐2885.2009.01153.x. Previously, dogs with canine parvovirus‐induced neutropenia have not responded to treatment with recombinant human granulocyte‐colony stimulating factor (rhG‐CSF). However, recombinant canine G‐CSF (rcG‐CSF) has not been previously evaluated for treatment of parvovirus‐induced neutropenia in dogs. We assessed the effectiveness of rcG‐CSF in dogs with parvovirus‐induced neutropenia with a prospective, open‐label, nonrandomized clinical trial. Endpoints of our study were time to recovery of WBC and neutrophil counts, and duration of hospitalization. 28 dogs with parvovirus and neutropenia were treated with rcG‐CSF and outcomes were compared to those of 34 dogs with parvovirus and neutropenia not treated with rcG‐CSF. We found that mean WBC and neutrophil counts were significantly higher (P < 0.05) in the 28 dogs treated with rcG‐CSF compared to disease‐matched dogs not treated with rcG‐CSF. In addition, the mean duration of hospitalization was reduced (P = 0.01) in rcG‐CSF treated dogs compared to untreated dogs. However, survival times were decreased in dogs treated with rcG‐CSF compared to untreated dogs. These results suggest that treatment with rcG‐CSF was effective in stimulating neutrophil recovery and shortening the duration of hospitalization in dogs with parvovirus infection, but indicate the need for additional studies to evaluate overall safety of the treatment. 相似文献
15.
In 1979 a canine parvovirus infection was widespread among dogs in Sweden. During the epizootic faecal samples were taken for bacteriological examination from 77 hospitalised dogs at an animal clinic. Forty-nine of the dogs had signs of gastroenteritis and they were all infected with canine parvovirus according to serological investigations. The remaining 28 dogs were referred to the clinic for other reasons.Campylobacter was isolated from 23 out of the 49 dogs with gastroenteritis and from 4 out of the 28 dogs lacking symptoms of enteritis. The significance of these findings is discussed. 相似文献
16.
犬细小病毒病的流行现状调查 总被引：3，自引：0，他引：3
对犬细小病毒病流行现状进行调查,为本病的预防、诊断和治疗提供依据。 用犬细小病毒抗原检测试剂盒对2008年门诊的具有腹泻、呕吐、粪便带血等体征的189只患犬作病原检测,对犬细小病毒阳性病例兼有发热、咳嗽体征的16例病犬同时作犬瘟热病毒抗原检测。结果犬细小病毒阳性病例共137只,发病年龄从1个月～15岁各年龄段均有分布,以6月龄以下幼龄动物发病较多,占65.7%。流行季节差异不大,以春季病例略多,占27.0%。犬细小病毒与犬瘟热病毒混合感染的有12例,占8.8%。对在疫苗接种免疫保护期内的4只患犬进行检测,3只犬细小病毒阳性。结论：①免疫力尚未建立是幼犬发病的主要原因;②不按规定的免疫程序对动物进行加强免疫是成年犬发病的主要原因;③在部分发病幼犬中存在犬细小病毒与犬瘟热病毒的混合感染;④老龄动物对免疫的应答能力下降可导致免疫失败。 相似文献
17.
为调查南京地区犬细小病毒(canine parvovirus,CPV)基因型分布情况,采集南京市某宠物医院2012—2019年犬细小病毒病患犬粪便43份作为检测病料,通过PCR扩增犬细小病毒VP2基因片段,并将扩增产物测序,分析CPV基因型。结果显示,43份病料皆扩增出目的片段,经测序后使用MegAlign软件与GenBank中犬细小病毒已知基因型对比分析,其中New-CPV-2a基因型为26株,占60.5%;New-CPV-2b基因型为9株,占20.9%;CPV-2c基因型为8株,占18.6%。研究结果表明,南京地区近年来犬细小病毒基因型发生了很大的变异,以New-CPV-2a为优势基因型,同时存在New-CPV-2b和CPV-2c基因型。本研究为南京地区预防和治疗犬细小病毒病提供理论依据。 相似文献
18.
S E Stann R F DiGiacomo W E Giddens J F Evermann 《Journal of the American Veterinary Medical Association》1984,185(6):651-655
From June 1980 through May 1982, 161 pound-source dogs that developed diarrhea while being used in research were evaluated to determine whether canine parvovirus (CPV) type 2 was the etiologic agent. Evaluation included notation of clinical signs, determination of serum CPV-specific immunoglobulin (Ig) M and IgG titers, virus isolation attempts, and histologic examination of tissues. Criteria for diagnosis of canine parvoviral enteritis were serum CPV-specific IgM antibodies, isolation of CPV from feces, and histologic evidence of intestinal crypt cell necrosis. Upon arrival, 67 clinically normal pound-source dogs were evaluated to determine the prevalence of fecal shedding of CPV and to determine their antibody titers to CPV. Parvovirus was not isolated from any of these dogs, although 76% had IgG antibodies and 3% had IgM antibodies. Of the 161 dogs with diarrhea, 40 (25%) had parvoviral enteritis. Of dogs with parvoviral enteritis, 71% had IgG antibodies and 68% had IgM antibodies. Canine parvovirus was isolated from 18 dogs. Serum IgG antibodies were found in 85% of dogs with diarrhea due to other causes. The geometric mean titer of IgG antibodies to CPV was not significantly different among the 3 groups. Clinical signs that appeared significantly (P less than 0.05) more often in dogs with parvoviral enteritis included bloody diarrhea, anorexia, fever (greater than or equal to 39.4 C), and leukopenia (WBC less than 6,000/mm3). Cases occurred throughout the year, without apparent seasonal variation. The duration between arrival and onset of diarrhea was significantly (P less than 0.05) shorter for dogs with parvoviral enteritis.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
19.
L Mishu G Callahan Z Allebban J M Maddux T C Boone L M Souza C D Lothrop 《Journal of the American Veterinary Medical Association》1992,200(12):1957-1964
Recombinant canine granulocyte colony-stimulating factor (rcG-CSF) was administered to clinically normal dogs, cyclic-hematopoietic dogs, and dogs undergoing autologous bone marrow transplantation, to determine whether rcG-CSF could be used to stimulate WBC production and function in normal and neutropenic dogs. To the normal dogs, rcG-CSF was administered by SC injection at rates of 1 microgram/kg of body weight, q 12 h; 2 micrograms/kg, q 12 h; or 5 micrograms/kg, q 12 h. A significant dose-dependent increase in the WBC count resulted from the stimulation of bone marrow progenitor cells. The increased WBC count was characterized by mature neutrophilia and monocytosis. Neutrophil myeloperoxidase and phagocytic activity were normal in rcG-CSF-treated normal dogs, demonstrating the production of normal functional neutrophils in response to rcG-CSF treatment. Recombinant canine G-CSF prevented neutropenia and associated clinical signs but did not completely eliminate the cycling of neutrophils in cyclic-hematopoietic dogs when it was administered at rates of 1 microgram/kg, q 12 h, and 2.5 micrograms/kg, q 12 h. The time to bone marrow reconstitution was not decreased in dogs treated with rcG-CSF at a rate of 2.5 micrograms/kg, q 12 h, for 13 days following autologous bone marrow transplantation. On the basis of our findings, we suggest that treatment with rcG-CSF is an effective way to stimulate myelopoiesis in dogs, but that the dose of rcG-CSF required to stimulate WBC production will vary depending on the cause of neutropenia. Recombinant canine G-CSF should be useful in stimulating production and maintaining function of WBC for treatment of clinical diseases seen commonly in veterinary practice. 相似文献
20.
Dewhurst EC Crawford E Cue S Dodkin S German AJ Papasouliotis K 《The Journal of small animal practice》2003,44(10):443-448
The VetScan HMT is an impedance counter haematology analyser which produces a full blood count and three-part white blood cell differential. The aim of this study was to compare the results generated by the analyser with those obtained by standard methods used routinely in the authors' laboratory. Blood samples from 68 dogs and 59 cats were run on the VetScan HMT analyser and also subjected to reference methods, and the results obtained were compared. Correlation coefficients (feline/canine) were: 0.97/0.99 for haematocrit (Hct), 0.98/0.99 for haemoglobin (Hb), 0.81/0.98 for total white blood cells (WBC), and 0.89/0.97 for granulocyte and 0.65/0.93 for platelet counts. Coefficients for lymphocyte counts were 0.25/0.28 and for monocyte counts were 0.12/0.79. In conclusion, the VetScan HMT performed well on canine samples, showing excellent correlation for canine Hct, Hb, RBC, WBC, granulocyte and platelet counts. For feline samples, although there was excellent correlation for Hct, Hb and RBC, the WBC and three-part white blood cell differential and platelet count should be interpreted with caution as they can be unreliable. 相似文献